Basal Chromogranin a and Gastrin Concentrations in Circulation Correlate to Endocrine Cell Proliferation in Type-A Gastritis

References

• Solcia E, Capella C, Buffa R, Osellini L, Fiocca R, Frigerio B. The diffuse endocrine-paracrine system of the gut in health and disease: ultrastructural features. Scand J Gastroenterol 1981; 16: 25–36, Suppl 70
   Web of Science ®Google Scholar
• Arnold R, Hülst MV, Neuhof CH, Schwarting H, Becker HD, Creutzfeldt W. Antral gastrin-producing G-cells and somatostatin-producing D-cells in different states of gastric acid secretion. Gut 1982; 23: 285–91
   PubMed Web of Science ®Google Scholar
• Håkanson R, Axelson J, Ekman R, Sundler F. Hypergastrinemia evoked by omeprazole stimulates growth of gastric mucosa but not of pancreas or intestines in hamster guinea pig and chicken. Regul Pept 1988; 23: 105–15
   PubMedGoogle Scholar
• Ryberg B, Tielemans Y, Axelson J, Carlsson E, Håkansson R, Matton H. Gastrin stimulates the self-replication rate of enterochromaffinlike cells in the rat stomach. Gastroenterology 1990; 99: 935–42
   PubMed Web of Science ®Google Scholar
• Bordi C, Costa A, Missale G. ECL cell proliferation and gastrin levels. Gastroenterology 1975; 68: 205–6
   PubMed Web of Science ®Google Scholar
• Borch K, Renvall H, Liedberg G, Andersen BN. Relations between circulating gastrin and endocrine cell proliferation in the atrophic gastric fundic mucosa. Scand J Gastroenterol 1986; 21: 357–63
   PubMed Web of Science ®Google Scholar
• Cattan D, Roucayrol A-M, Launay J-M, Callebert J, Charasz N, Nurit Y. Circulating gastrin, endocrine cells, histamine content, and histidine decarboxylase activity in atrophic gastritis. Gastroenterology 1989; 97: 586–96
   PubMed Web of Science ®Google Scholar
• Bordi C, Cocconi G, Togni R, Vezzadini P, Missale G. Gastric endocrine cell proliferation. Association with Zollinger-Ellison syndrome. Arch Pathol 1974; 98: 274–9
   PubMedGoogle Scholar
• Solcia E, Capella C, Fiocca R, Rindi G, Rosai J. Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type I multiple endocrine neoplasia. A newly recognized association. Am J Surg Pathol 1990; 14: 503–13
   PubMed Web of Science ®Google Scholar
• Borch K. Atrophic gastritis and carcinoid tumours. Ann Med 1989; 21: 291–7
   PubMed Web of Science ®Google Scholar
• Solcia E, Fiocca R, Villani L, Gianatti A, Cornaggia M, Chiaravalli A. Morphology and pathogenesis of endocrine hyperplasias, precarcinoid lesions, and carcinoids arising in chronic atrophic gastritis. Scand J Gastroenterol 1991; 26: 146–59, Suppl 180
   PubMed Web of Science ®Google Scholar
• Borch K, Renvall H, Liedberg G. Gastric endocrine cell hyper-plasia and carcinoid tumours in pernicious anemia. Gastroenterology 1985; 88: 638–48
   PubMed Web of Science ®Google Scholar
• Sjöblom S-M, Haapiainen R, Miettinen M, Järvinen H. Gastric carcinoid tumours and atrophic gastritis. Acta Chir Scand 1987; 153: 37–43
   PubMedGoogle Scholar
• Winkler H, Fisher-Colbrie R. The chromogranins A and B: the first 25 years and future perspectives. Neuroscience 1992; 49: 497–528
   PubMed Web of Science ®Google Scholar
• Hendy GN, Bevan S, Mattel M-G, Mouland AJ, Chromogranin A. Clin Invest Med 1995; 18: 47–65
   PubMedGoogle Scholar
• Stabile BE, Howard TJ, Passaro E, Jr, O'Connor DT. Source of plasma chromogranin A elevation in gastrinoma patients. Arch Surg 1990; 125: 451–3
   PubMedGoogle Scholar
• Syversen U, Mignon M, Bonfils S, Kristensen A, Waldum HL. Chromogranin A and pancreastatin-like immunoreactivity in serum of gastrinoma patients. Acta Oncol 1993; 32: 161–5
   PubMed Web of Science ®Google Scholar
• Belaiche J, Delwaide J, Vivario M, Gast P, Louis E, Boniver J. Fundic argyrophil cell hyperplasia in alrophic gastritis: a search for a sensitive diagnostic method. Acta Gastroenterol Belg 1993; 56: 11–7
   PubMedGoogle Scholar
• Fahrenkamp AG, Wibbeke C, Winde G, Ofner D, Blocker W, Fisher-Colbrie R. Immunohistochemical distribution of chromogranins A and B and secretogranin II in neuroendocrine tumours of the gastrointestinal tract. Virchows Arch 1995; 426: 361–7
   PubMedGoogle Scholar
• Borch K, Liedberg G. Prevalence and incidence of pernicious anemia. An evaluation for gastric screening. Scand J Gastroenterol 1984; 19: 154–60
   PubMed Web of Science ®Google Scholar
• Borch K, Renvall H, Kullman E, Wilander E. Gastric carcinoid associated with the syndrome of hypergastrinemic atrophic gastritis. A prospective analysis of 11 cases. Am J Surg Pathol 1987; 11: 435–44
   PubMed Web of Science ®Google Scholar
• Jacobsen M, Clausen PP, Smidth S. The effect of fixation and trypsinization on the immunohistochemical demonstration of intraccllular immunoglobulin in paraffin embedded material. Acta Pathol Microbiol Scand [G] 1980; 88: 369–76
   PubMedGoogle Scholar
• Stridsberg M, Hellman U, Wilander E, Lundqvist G, Hellsing K, Öberg K. Fragments of chromogranin A are present in the urine of patients with carcinoid tumours: development of a specific radioimmunoassay for chromogranin A and its fragments. J Endocrinol 1993; 139: 329–37
   PubMed Web of Science ®Google Scholar
• Stridsberg M, Oberg K, Li Q, Engström U, Lundqvist G. Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours. J Endocrinol 1995; 144: 49–59
   PubMed Web of Science ®Google Scholar
• Price A. The Sydney System: histological division. J Gastroenterol Hcpatol 1991; 6: 209–22
   PubMed Web of Science ®Google Scholar
• Anderson JM. Histometry. Theory and practice of histological techniques, JD Bancroft, A Stevens. Churchill Livingstone, Edinburgh 1982; 548–63
   Google Scholar
• Rehfeld JF, Stadil F, Rubin B. Production and evaluation of antibodies for the radioimmunoassay of gastrin. Scand J Clin Lab Invest 1972; 30: 221–32
   PubMed Web of Science ®Google Scholar
• Rehfeld JF. Sequence-specific radioimmunoassays for gastrin cholecystokinin and somatostatin. Biomed Res 1980; 1: 73–8
   Google Scholar
• Waldum HL, Amestad JS, Brenna E, Eide I, Syversen U, Sandvik AK. Marked increase in gastric acid secretory capacity after omeprazole treatment. Gastroenterology 1996; 110: A289
   Google Scholar